• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过黑质移植实现去传入新纹状体的功能再激活。

Functional reactivation of the deafferented neostriatum by nigral transplants.

作者信息

Björklund A, Stenevi U, Dunnett S B, Iversen S D

出版信息

Nature. 1981 Feb 5;289(5797):497-9. doi: 10.1038/289497a0.

DOI:10.1038/289497a0
PMID:6258079
Abstract

Functional deficits following brain lesions can be due not only to the disruption of conduction in specific input and output pathways passing through the site of injury, but also to the loss of important regulatory systems controlling the functional state of neuronal circuitries in areas distant from the lesion. For example, the behavioural disturbances that result from lesions of the nigrostriatal dopamine (DA) pathways can be reversed by administration of dopamine receptor-activating drugs, such as L-dopa or apomorphine. This suggests that the lesioned dopaminergic system, rather than conveying specific input and output signals, is normally acting on neuronal machineries whose activity levels are set by the activity at the dopaminergic synapses. Thus the neurological deficits resulting from these lesions are due to functional inactivation of otherwise intact neostriatal circuitries. Previous studies have shown that intracerebral transplants of embryonic substantia nigra can compensate for drug-induced as well as spontaneous asymmetric motor behaviour (expressed as a tendency to move in circles towards the lesioned side), whereas the sensorimotor asymmetry, which is pronounced in rats with a unilateral lesion of the nigrostriatal DA pathway, was unaffected by the transplant. We report here that restoration of striatal dopaminergic neurotransmission by nigral transplants in animals with bilateral, complete lesions of the nigral transplants in animals with bilateral, complete lesions of the nigrostriatal DA pathways can reinstate not only certain aspects of spontaneous motor behavior, but also sensorimotor orientation and sensory attention on the side of the body contralateral to the graft.

摘要

脑损伤后的功能缺陷不仅可能是由于穿过损伤部位的特定输入和输出通路的传导中断,还可能是由于控制远离损伤部位的神经元回路功能状态的重要调节系统的丧失。例如,黑质纹状体多巴胺(DA)通路损伤导致的行为障碍可以通过给予多巴胺受体激活药物(如左旋多巴或阿扑吗啡)来逆转。这表明,受损的多巴胺能系统并非传递特定的输入和输出信号,而是通常作用于其活动水平由多巴胺能突触处的活动设定的神经元机制。因此,这些损伤导致的神经功能缺陷是由于原本完整的新纹状体回路功能失活所致。先前的研究表明,胚胎黑质的脑内移植可以补偿药物诱导的以及自发的不对称运动行为(表现为向损伤侧转圈的倾向),而在黑质纹状体DA通路单侧损伤的大鼠中明显的感觉运动不对称不受移植的影响。我们在此报告,在双侧黑质纹状体DA通路完全损伤的动物中,通过黑质移植恢复纹状体多巴胺能神经传递不仅可以恢复自发运动行为的某些方面,还可以恢复移植对侧身体的感觉运动定向和感觉注意力。

相似文献

1
Functional reactivation of the deafferented neostriatum by nigral transplants.通过黑质移植实现去传入新纹状体的功能再激活。
Nature. 1981 Feb 5;289(5797):497-9. doi: 10.1038/289497a0.
2
Reinnervation of the denervated striatum by substantia nigra transplants: functional consequences as revealed by pharmacological and sensorimotor testing.黑质移植对失神经支配纹状体的再支配:药理学和感觉运动测试揭示的功能后果
Brain Res. 1980 Oct 20;199(2):307-33. doi: 10.1016/0006-8993(80)90692-7.
3
Behavioural recovery following transplantation of substantia nigra in rats subjected to 6-OHDA lesions of the nigrostriatal pathway. II. Bilateral lesions.黑质纹状体通路6-羟基多巴胺损伤大鼠移植黑质后的行为恢复。II. 双侧损伤
Brain Res. 1981 Dec 21;229(2):457-70. doi: 10.1016/0006-8993(81)91007-6.
4
Behavioural recovery following transplantation of substantia nigra in rats subjected to 6-OHDA lesions of the nigrostriatal pathway. I. Unilateral lesions.黑质纹状体通路6-羟基多巴胺损伤大鼠移植黑质后的行为恢复。I. 单侧损伤。
Brain Res. 1981 Jun 29;215(1-2):147-61. doi: 10.1016/0006-8993(81)90498-4.
5
Grafts of embryonic substantia nigra reinnervating the ventrolateral striatum ameliorate sensorimotor impairments and akinesia in rats with 6-OHDA lesions of the nigrostriatal pathway.胚胎黑质移植重新支配腹外侧纹状体可改善黑质纹状体通路6-羟基多巴胺损伤大鼠的感觉运动障碍和运动不能。
Brain Res. 1981 Dec 14;229(1):209-17. doi: 10.1016/0006-8993(81)90759-9.
6
Dopaminergic innervation of substance P-containing striatal neurons by fetal nigral grafts: an ultrastructural double-labeling immunocytochemical study.胎儿黑质移植物对含P物质的纹状体神经元的多巴胺能神经支配:超微结构双标记免疫细胞化学研究
J Comp Neurol. 1991 Jun 1;308(1):66-78. doi: 10.1002/cne.903080107.
7
Transsynaptic effect of an intrastriatal fetal nigral graft on the sensitivity of the substantia nigra pars reticulata to muscimol in the rat.纹状体内胎儿黑质移植对大鼠黑质网状部对蝇蕈醇敏感性的跨突触效应。
Exp Neurol. 1994 May;127(1):45-53. doi: 10.1006/exnr.1994.1078.
8
Functional repair of striatal systems by neural transplants: evidence for circuit reconstruction.神经移植对纹状体系统的功能修复:回路重建的证据
Behav Brain Res. 1995 Jan 23;66(1-2):133-42. doi: 10.1016/0166-4328(94)00134-2.
9
Reconstruction of the striato-nigro-striatal circuitry by simultaneous double dopaminergic grafts: a tracer study using fluorogold and horseradish peroxidase.通过同时进行双多巴胺能移植重建纹状体-黑质-纹状体回路:一项使用荧光金和辣根过氧化物酶的示踪研究
Brain Res. 1997 Dec 5;778(1):194-205. doi: 10.1016/s0006-8993(97)01055-x.
10
Interactions of D1 and D2 dopamine receptors on the ipsilateral vs. contralateral side in rats with unilateral lesions of the dopaminergic nigrostriatal pathway.多巴胺能黑质纹状体通路单侧损伤大鼠同侧与对侧D1和D2多巴胺受体的相互作用。
J Pharmacol Exp Ther. 1988 Oct;247(1):180-5.

引用本文的文献

1
Dopaminergic Cell Replacement for Parkinson's Disease: Addressing the Intracranial Delivery Hurdle.帕金森病的多巴胺能细胞替代治疗:解决颅内递药难题。
J Parkinsons Dis. 2024;14(3):415-435. doi: 10.3233/JPD-230328.
2
Can pluripotent/multipotent stem cells reverse Parkinson's disease progression?多能/多潜能干细胞能逆转帕金森病的病情进展吗?
Front Neurosci. 2024 Jan 31;18:1210447. doi: 10.3389/fnins.2024.1210447. eCollection 2024.
3
Endogenous exogenous cell replacement for Parkinson's disease: where are we at and where are we going?
帕金森病的内源性和外源性细胞替代治疗:我们目前的进展及未来方向?
Neural Regen Res. 2022 Dec;17(12):2637-2642. doi: 10.4103/1673-5374.336137.
4
Emerging regenerative medicine and tissue engineering strategies for Parkinson's disease.帕金森病的新兴再生医学与组织工程策略
NPJ Parkinsons Dis. 2020 Jan 8;6:4. doi: 10.1038/s41531-019-0105-5. eCollection 2020.
5
Cell-based therapy for Parkinson's disease: A journey through decades toward the light side of the Force.基于细胞的帕金森病治疗:穿越数十年,走向原力光明面的旅程。
Eur J Neurosci. 2019 Feb;49(4):463-471. doi: 10.1111/ejn.14109. Epub 2018 Sep 9.
6
Replacing Dopamine Neurons in Parkinson's Disease: How did it happen?替换帕金森病中的多巴胺能神经元:这是如何发生的?
J Parkinsons Dis. 2017;7(s1):S21-S31. doi: 10.3233/JPD-179002.
7
Cell therapies for Parkinson's disease: how far have we come?帕金森病的细胞疗法:我们进展到了什么程度?
Regen Med. 2016 Dec;11(8):777-786. doi: 10.2217/rme-2016-0102. Epub 2016 Nov 25.
8
Cyclosporin promotes neurorestoration and cell replacement therapy in pre-clinical models of Parkinson's disease.环孢素促进帕金森病临床前模型中的神经修复和细胞替代治疗。
Acta Neuropathol Commun. 2015 Dec 14;3:84. doi: 10.1186/s40478-015-0263-6.
9
Cell-based therapies for Parkinson disease—past insights and future potential.基于细胞的帕金森病疗法——过去的见解和未来的潜力。
Nat Rev Neurol. 2015 Sep;11(9):492-503. doi: 10.1038/nrneurol.2015.123. Epub 2015 Aug 4.
10
Treating Parkinson's disease in the 21st century: can stem cell transplantation compete?21世纪帕金森病的治疗:干细胞移植能否与之竞争?
J Comp Neurol. 2014 Aug 15;522(12):2802-16. doi: 10.1002/cne.23577. Epub 2014 Apr 4.